PFNLive
- Novartis Says New Drug Brings Relief to Lung Patients
- AbbVie Hepatitis C Drugs Knock out Virus at 8 Weeks
- Illumina Jumps Most in 15 Months on First-Quarter Profit
- Sucampo Wins Approval for Expanded Use of Amitiza in U.S.
- Biogen MS Pill Soars Onstage with Impressive First-Week Script Numbers
- Stocks Briefly Drop, Recover, on Fake Bomb Tweet
- Bristol-Myers Hepatitis C Combo Therapy Blunts Disease
- Achillion Says Hepatitis C Drug Subdues Virus in 63% of Patients
- Orion Profit Falls on Generic Competition
- Wall Street Ends Higher, Led by Tech, Microsoft
- AstraZeneca Inks Cancer Deals with Bind Therapeutics, Horizon Discovery
- Bristol-Myers Rebounds on Hep C Front with New Merck Partnership
- Stocks Mixed as Major Companies Report Earnings
- Severe U.S. Flu Season Helps Reckitt Top Forecasts
- Sanofi Infant Vaccine gets EU Approval
- Stock Futures up with Full Earnings Calendar on Tap
- TiGenix Reports Positive Phase IIa Results in Arthritis
- Elan Board Unanimously Rejects Royalty Pharma Bid
- Takeda in More Trouble at Home over Recall of Mislabeled Vials
- Nasdaq Extends Gain, up 1 Percent on Tech Results
